Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04889079 · ClinicalTrials.gov registry record
Assessing Adolescent Use of Nexplanon Over Time
A clinical trial of Contraception, sponsored by University of Utah.
- Active
- Registry status
- 255
- Enrollment target
- 1
- Study location
NCT04889079: Active study of Contraception, sponsored by University of Utah.
NCT04889079 is a study of Contraception that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 255 participants, below the 451-participant average among 72 other Contraception trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04889079, a study of Contraception, is active but no longer recruiting, sponsored by University of Utah.
- ACTIVE NOT RECRUITING
- Registry status
- 255 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare Nexplanon decision-making, uptake, satisfaction and contraceptive outcomes (continuation, switching, discontinuation) over a 12-month period among adolescents ages 15-18 to adolescents ages 19-24, living in Utah. Data from this study will provide valuable information for clinical and public health offerings, counseling and support for Nexplanon use across stages of adolescence.
Conditions Studied
Interventions
- BEHAVIORAL Contraceptive use (continuation/switching/discontinuation)
Study Locations (1)
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2021-06-06 |
| Est. Completion | 2025-05-30 |
What the registry record for NCT04889079 still lists
NCT04889079 is an observational study that tracks outcomes without assigning an intervention. The registered 255 participants enrollment target is mid-sized for trials with a published cap, below the 451-participant average among 72 other Contraception trials with a reported enrollment target (43% lower).
The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which Contraceptive use (continuation/switching/discontinuation) is the first listed.
NCT04889079 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT04889079 about?
NCT04889079 is a clinical study titled "Assessing Adolescent Use of Nexplanon Over Time". The purpose of this study is to compare Nexplanon decision-making, uptake, satisfaction and contraceptive outcomes (continuation, switching, discontinuation) over a 12-month period among adolescents ages 15-18 to adolescents ages 19-24, living in Utah. Data from this study will provide valuable info...
What is the current status of trial NCT04889079?
This trial is currently active not recruiting. The enrollment target is 255 participants. The study started on 2021-06-06. Estimated completion is 2025-05-30.
What conditions does trial NCT04889079 study?
This clinical trial studies the following conditions: Contraception.
What interventions are being tested in trial NCT04889079?
The interventions under investigation include: Contraceptive use (continuation/switching/discontinuation) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04889079?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04889079 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04889079's enrollment target sits among peer trials
255 29th of 72 higher than 44 of 72 other Contraception trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oral Contraceptive Pill (OCP) Pharmacogenomics
RECRUITING · Phase 4
-
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
RECRUITING · Phase 4
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04623424 · 255 participants
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
- NCT05114798 · 255 participants · NA
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers
- NCT05336188 · 255 participants · Phase 2
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
- NCT05486637 · 255 participants · Early Phase 1
Vocal Emotion Communication With Cochlear Implants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI